Glycodiazine

Clinical data
Routes of administration	Oral
ATC code	A10BC01 (WHO)
Pharmacokinetic data
Bioavailability	High
Protein binding	90%
Elimination half-life	3.8 hours
Identifiers
IUPAC name N-[5-(2-methoxyethoxy)pyrimidin-2-yl]benzenesulfonamide
CAS Number	339-44-6 Y
PubChem CID	9565
DrugBank	DB01382 Y
ChemSpider	9190 Y
UNII	4C5I4BQZ8F
ChEBI	CHEBI:31660
ChEMBL	ChEMBL1697838 N
CompTox Dashboard (EPA)	DTXSID1023108
ECHA InfoCard	100.005.842
Chemical and physical data
Formula	C13H15N3O4S
Molar mass	309.34 g·mol−1
3D model (JSmol)	Interactive image
SMILES O=S(=O)(Nc1ncc(OCCOC)cn1)c2ccccc2
InChI InChI=1S/C13H15N3O4S/c1-19-7-8-20-11-9-14-13(15-10-11)16-21(17,18)12-5-3-2-4-6-12/h2-6,9-10H,7-8H2,1H3,(H,14,15,16) Y Key:QFWPJPIVLCBXFJ-UHFFFAOYSA-N Y
NY (what is this?)  (verify)

Glymidine sodium (INN, also known as glycodiazine; trade name Gondafon) is a sulfonamide antidiabetic drug, structurally related to the sulfonylureas. It was first reported in 1964, and introduced to clinical use in Europe in the mid to late 1960s.^[1]

References